These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37984527)

  • 1. Hyperplasia of the retinal pigment epithelium secondary to subthreshold laser treatment in chronic central serous chorioretinopathy.
    Enríquez-Fuentes JE; Alarcón-García AD; Oribio-Quinto C; Fernández-Vigo JI
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103896. PubMed ID: 37984527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
    Enders C; Lang GE; Mayer B; Werner JU
    Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy.
    Zheng F; He J; Su Z; Liu Y; Xu Y; Liu L; Ye P
    BMC Ophthalmol; 2022 Jun; 22(1):252. PubMed ID: 35668416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.
    Yasui A; Yamamoto M; Hirayama K; Shiraki K; Theisen-Kunde D; Brinkmann R; Miura Y; Kohno T
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):243-254. PubMed ID: 27497611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial.
    van Dijk EHC; Fauser S; Breukink MB; Blanco-Garavito R; Groenewoud JMM; Keunen JEE; Peters PJH; Dijkman G; Souied EH; MacLaren RE; Querques G; Downes SM; Hoyng CB; Boon CJF
    Ophthalmology; 2018 Oct; 125(10):1547-1555. PubMed ID: 29776672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
    Shin YU; Lee BR
    Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Dijkman G; Peters PJH; Tsonaka R; Keunen JEE; MacLaren RE; Hoyng CB; Downes SM; Fauser S; Boon CJF
    Acta Ophthalmol; 2021 Nov; 99(7):805-811. PubMed ID: 33565230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
    Yadav NK; Jayadev C; Mohan A; Vijayan P; Battu R; Dabir S; Shetty B; Shetty R;
    Eye (Lond); 2015 Feb; 29(2):258-64; quiz 265. PubMed ID: 25613846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Altinel MG; Kanra AY; Totuk OMG; Ardagil A; Turkmen OF
    J Fr Ophtalmol; 2021 Apr; 44(4):499-508. PubMed ID: 33642060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data.
    Subhi Y; Bjerager J; Boon CJF; van Dijk EHC
    Acta Ophthalmol; 2022 Feb; 100(1):89-95. PubMed ID: 33998168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal pigment epithelium aperture in acute central serous chorioretinopathy: Another novel possible pathological mechanism.
    Lei C; Hua R; Duan J; Zhang M
    Eur J Ophthalmol; 2022 Jul; 32(4):NP103-NP108. PubMed ID: 33719657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors.
    Hwang S; Kang SW; Kim SJ; Jang JW; Kim KT
    Retina; 2019 Jun; 39(6):1117-1124. PubMed ID: 29517581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.
    Uzlu D; Erdöl H; Kola M; Özbay AD
    Lasers Med Sci; 2021 Jul; 36(5):981-988. PubMed ID: 32812130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy.
    Iovino C; Chhablani J; Parameswarappa DC; Pellegrini M; Giannaccare G; Peiretti E
    Eye (Lond); 2019 Dec; 33(12):1871-1876. PubMed ID: 31267093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subretinal hyperreflective material in central serous chorioretinopathy.
    Sahoo NK; Govindhari V; Bedi R; Goud A; Singh R; Wu L; Chhablani J
    Indian J Ophthalmol; 2020 Jan; 68(1):126-129. PubMed ID: 31856489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.